(Press-News.org) A new study led by researchers at the Department of Population Medicine - Harvard Pilgrim Health Care Institute, Boston Medical Center, and Boston University School of Public Health finds that how Medicaid programs are designed can make a big difference in the care pregnant and postpartum people receive.
The study, “Medicaid Accountable Care Model Designs and Maternal Health Measures”, was published October 8 in JAMA Network Open.
Maternal health care in the U.S. is in crisis. There is an urgent need to identify models of care that may improve maternal health outcomes, especially within Medicaid, which covers over 40% of U.S. births. Medicaid accountable care organizations (ACOs) – groups of health care providers that work together to improve patient care and lower costs - are one potential mechanism for doing so, but there is very little evidence about if and how Medicaid ACOs affect maternal health care.
Researchers compared two types of ACOs: those led by primary care practices and those formed through a health system/managed care organization partnership. Specifically, they looked at over 67,000 births covered by Medicaid in Massachusetts between 2014 and 2020.
They found that:
Primary care-led ACOs helped increase doctor visits during pregnancy and after birth, allowing pregnant and post-partum patients to stay more engaged in their care.
Health system-led ACOs were linked to fewer emergency room visits and more timely postpartum care.
Both types of ACOs improved screening for postpartum depression.
“These findings suggest that Medicaid ACOs hold promise in improving some maternal health outcomes,” said lead author Megan Cole, Member of the Faculty at Harvard Medical School and the Department of Population Medicine. “But their ability to do so may depend on how the ACO is designed.”
The study highlights the importance of thoughtful value-based care delivery design within Medicaid programs. With 37 states still without Medicaid ACOs and 13 considering changes, this research offers timely guidance for policymakers.
“As states and health systems consider how to improve maternal health care through value-based payment models, little evidence is available to guide them,” Dr. Cole added. “This study provides critical new evidence to state Medicaid programs, health systems, and policymakers as they consider how to design and implement Medicaid ACOs in a way that improves maternal health outcomes for low-income women.”
The authors hope their findings will help states and health systems build better care models that support moms before, during, and after pregnancy.
About the Harvard Pilgrim Health Care Institute’s Department of Population Medicine
The Harvard Pilgrim Health Care Institute's Department of Population Medicine is a unique collaboration between Harvard Pilgrim Health Care and Harvard Medical School. Created in 1992, it is the first appointing medical school department in the United States based in a health plan. The Institute focuses on improving health care delivery and population health through innovative research and education, in partnership with health plans, delivery systems, and public health agencies. Follow us on Bluesky, X, and LinkedIn.
END
Medicaid innovation models improve care for moms, but design matters
2025-10-08
ELSE PRESS RELEASES FROM THIS DATE:
Cannabis use among individuals with psychosis after state-level commercial cannabis legalization
2025-10-08
About The Study: In this study, individuals with psychosis reported a large increase in current cannabis use following legalization and commercialization of cannabis in their state, and by larger amounts than previously reported estimates of the general population. Given how cannabis can negatively affect illness course and health service utilization in individuals with psychosis, these results should be considered by regulators designing policies around taxation, potency, advertising, and health warnings.
Corresponding Author: To contact ...
Open-label placebos as adjunct for the preventive treatment of migraine
2025-10-08
About The Study: In this randomized clinical trial, open-label placebo treatment did not reduce headache frequency but was associated with improvements in quality of life and pain-related disability. Future research should clarify the mechanisms underlying these effects and determine their potential supportive role in migraine care for selected patients.
Corresponding Author: To contact the corresponding author, Julian Kleine-Borgmann, MD, email julian.kleineborgmann@uk-essen.de.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.35739)
Editor’s Note: Please ...
Moon's biggest impact crater made a radioactive splash
2025-10-08
When astronauts land near the moon's south pole as part of NASA's Artemis program in a few years, they likely will find themselves in an unexpected treasure trove of clues that could help scientists better understand how Earth's only natural satellite came to be. That's according to a new study led by Jeffrey Andrews-Hanna, a planetary scientist at the University of Arizona.
Published on Oct. 8 in the journal Nature, the paper also provides a snapshot of the moon's tumultuous past that could help explain longstanding puzzles such as why the moon's crater-riddled far side is so dramatically different from its smooth ...
Smoking and biological sex shape healthy bladder tissue evolution, offering clues to cancer risk
2025-10-08
A study published in Nature by researchers at IRB Barcelona and the University of Washington shows that smoking and biological sex influence how mutated cells expand in healthy bladder tissue.
The findings may help explain why men and smokers are more likely to develop bladder cancer.
The novel approach used in this study reveals many more mutations than previously detected.
The research aims to pave the way for prevention and early detection tools in bladder cancer.
Barcelona, 8 October 2025 – Bladder cancer is one of the most common cancers worldwide. Men are around four times more likely to develop it than women, and smoking is the main known environmental risk factor. However, ...
Improved genetic tool reveals hidden mutations that can drive cancer
2025-10-08
Researchers have refined a powerful DNA sequencing tool that can uncover hidden mutations that occur naturally in our bodies as we age. In the largest study to date, they have used the tool to provide insights into the earliest steps of cancer development and the role of mutations in healthy tissue.
The new study, published today (8 October) in Nature, was led by researchers from the Wellcome Sanger Institute, in collaboration with the TwinsUK study at King’s College London. The researchers introduce an improved version of nanorate sequencing (NanoSeq) – an ultra-accurate DNA sequencing technique.
By applying targeted NanoSeq ...
Hidden evolution in sperm raises disease risk for children as men age
2025-10-08
Harmful genetic changes in sperm become substantially more common as men age because some are actively favoured during sperm production, new research has revealed.
In a landmark study published today (8 October) in Nature, researchers from the Wellcome Sanger Institute, in collaboration with the TwinsUK study at King’s College London, have comprehensively mapped how harmful DNA changes in sperm cells can increase across the genome as men age.
The findings create new possibilities to explore how lifestyle and environmental factors might influence genetic risks passed on to future generations.
In ...
Women portrayed as younger than men online, and AI amplifies the bias
2025-10-08
U.S. Census data shows no systematic age differences between men and women in the workforce over the past decade. And globally, women on average live about five years longer than men. But that’s not what you’ll see if you search Google or YouTube or query an AI like ChatGPT.
A study published today in the journal Nature analyzed 1.4 million online images and videos plus nine large language models trained on billions of words and found that women are systematically presented as younger than men. The researchers looked at content from Google, Wikipedia, IMDb, Flickr, and YouTube, and major large language models including GPT2, and concluded ...
Engineered bacterial therapy activates immune response in cancer preclinical studies
2025-10-08
“ACTM-838 showed durable anti-tumor efficacy in multiple murine tumor models and synergized with anti-PD1 therapy in combination.”
BUFFALO, NY – October 8, 2025 – A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled “ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response.”
In this study, led by first author Kyle R. Cron and corresponding ...
Energy flexibility is reshaping Finland’s electricity market
2025-10-08
The future of the electricity market may depend less on big power plants and more on everyday choices made at home. Nayeem Rahman’s dissertation at the University of Vaasa shows how consumers are gaining influence through energy flexibility, with direct implications for sustainability and costs.
For decades, the low cost of electricity provided little incentive for consumers to change their energy consumption habits. However, as prices surged due to the energy crisis that followed Russia’s invasion of Ukraine, many ...
Individuals with sickle cell disease face long delays to pain care in emergency department
2025-10-08
(WASHINGTON — October 8, 2025) – Most individuals living with sickle cell disease who presented to the emergency department with a pain crisis, known as vaso-occlusive crisis (VOC), were not triaged appropriately according to established national guidelines, reveals a study published today in Blood Advances. Patients triaged with a less severe category waited nearly three times as long for their first dose of pain medication when compared to individuals with sickle cell disease who were triaged appropriately.
“Pain is a significant burden in the day-to-day lives of those living with sickle cell ...